The European Medicines Agency (EMA) and the European Centre for Disease Control (ECDC) recommend targeting people at risk in ...

The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...

A vaccine for pregnant women, which can protect their infants from the RSV illness after birth, has been approved by the U.S. Food and Drug Administration. The FDA recently approved Abrysvo, a ...

New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns. The Centers ...

GSK plc (GSK, GSK.L) said Japan's Ministry of Health, Labour and Welfare has approved Arexvy for the prevention of respiratory ...

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60. Arexvy is a vaccine used for the prevention of respiratory syncytial ...

Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease.

Visiongain has published a new report entitled Anti-infective Vaccines Market Report 2023-2033: Forecasts by Vaccine Type (Seasonal Influenza Vaccine, Shingles, Tdap Containing /DTaP Primary Vaccine, ...

GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare ...

While we’re talking vaccines this fall, this is what you should know about getting vaccinated against shingles.

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns.